Cited by 11,090Psychological Testing and AssessmentAnxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesPsychometric Methodologies and Testing

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

The Brief Psychiatric Rating Scale.

Overall, John E., Gorham, Donald R.·1962·Psychological Reports

DOI 10.2466/pr0.1962.10.3.799

Open this paper in CoChat — free account

Integrity signals

Registry

Crossref · 10.2466/pr0.1962.10.3.799

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Drug therapy in depressions: Controlled evaluation of imipramine, isocarboxazide, dextroamphetamine‐amobarbital, and placebo
Overall, J. E., Hollister, L. E., Pokorny, A. D., Casey, J. F., & Katz, G. M. (1962) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt19623116 · Cited by 84
Self-citation
Basic dimensions of change in the symptomatology of chronic schizophrenics.
Overall, J. E., Gorham, D. R., & Shawver, J. R. (1961) · Journal of Abnormal & Social Psychology · doi:10.1037/h0039893 · Cited by 28
Self-citation
DRUG-ACTION PROFILES BASED ON AN ABBREVIATED PSYCHIATRIC RATING SCALE
Gorham, D. R., & Overall, J. E. (1960) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-196012000-00007 · Cited by 20
Self-citation
Dimensions of change in psychiatric symptomatology.
Dr, G., & Overall, J. E. (1961) · PubMed · Cited by 14
Self-citation

Show all 4 references

Research works printed but not linked: 2

Gorham D. R., 1961, Dis. nerv. System, 22, 576
Lorr M., 1960, Amer. Psychologist, 15, 495

Sorted by citations

Items 101–200 of 421

Cognitive enhancement therapy for early-course schizophrenia: effects of a two-year randomized controlled trial
Eack, S. M., Greenwald, D. P., Hogarty, S. S., Cooley, S. J., DiBarry, A. L., Montrose, D. M., & Keshavan, M. S. (2009) · Psychiatric Services · doi:10.1176/ps.2009.60.11.1468 · Cited by 289
A Double-Blind, Placebo-Controlled Trial Assessing the Efficacy of Varenicline Tartrate for Alcohol Dependence
Litten, R. Z., Ryan, M. L., Fertig, J. B., Falk, D. E., Johnson, B., Dunn, K. E., Green, A. I., Pettinati, H. M., Ciraulo, D. A., Sarid-Segal, O., et al. (2013) · Journal of Addiction Medicine · doi:10.1097/adm.0b013e31829623f4 · Cited by 287
Relationship of ketamine's plasma metabolites with response, diagnosis, and side effects in major depression
Zarate, C. A., Brutsche, N., Laje, G., Luckenbaugh, D. A., Venkata, S. L. V., Ramamoorthy, A., Moaddel, R., & Wainer, I. W. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.03.004 · Cited by 282
Do the dissociative side effects of ketamine mediate its antidepressant effects?
Luckenbaugh, D. A., Niciu, M. J., Ionescu, D. F., Nolan, N. M., Richards, E. M., Brutsche, N. E., Guevara, S., & Zarate, C. A. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.02.017 · Cited by 283
Volumetric Measure of the Frontal and Temporal Lobe Regions in Schizophrenia: Relationship to Negative Symptoms
Sanfilipo, M., Lafargue, T., Rusinek, H., Arena, L., Loneragan, C., Lautin, A., Feiner, D., Rotrosen, J., & Wolkin, A. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.5.471 · Cited by 281
Increased Anterior Cingulate Cortical Activity in Response to Fearful Faces: A Neurophysiological Biomarker that Predicts Rapid Antidepressant Response to Ketamine
Salvadore, G., Cornwell, B. R., Colon-Rosario, V., Coppola, R., Grillon, C., Zarate, C. A., & Manji, H. K. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.08.014 · Cited by 277
Disturbances in Body Ownership in Schizophrenia: Evidence from the Rubber Hand Illusion and Case Study of a Spontaneous Out-of-Body Experience
Thakkar, K. N., Nichols, H. S., McIntosh, L. G., & Park, S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027089 · Cited by 264
Outcomes of Nontransitioned Cases in a Sample at Ultra-High Risk for Psychosis
Lin, A., Wood, S. J., Nelson, B., Beavan, A., McGorry, P., & Yung, A. R. (2015) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2014.13030418 · Cited by 277
The role of sleep dysfunction in the occurrence of delusions and hallucinations: A systematic review
Reeve, S., Sheaves, B., & Freeman, D. (2015) · Clinical Psychology Review · doi:10.1016/j.cpr.2015.09.001 · Cited by 273
“Y SAPS = Scale for Assessment of Positive Symptoms (Andreasen, 1984); HAM-D= Hamilton Depression Rating Scale (Hamilton, 1960); Bunney–Hamburg Scale (Bunney & Hamburg, 1963); PSG = Polysomnography (see Tables 1a for definition); BPRS = Brief Psychiatric Rating Scale (Overall & Gorham, 1962); PANSS = Positive and Negat…”
BackgroundMethodInfluential
Antipsychotic-Induced Dopamine Supersensitivity Psychosis: Pharmacology, Criteria, and Therapy
Chouinard, G., Samaha, A.-N., Chouinard, V.-A., Peretti, C.-S., Kanahara, N., Takase, M., & Iyo, M. (2017) · Psychotherapy and Psychosomatics · doi:10.1159/000477313 · Cited by 270
The REACT study: randomised evaluation of assertive community treatment in north London
Killaspy, H., Bebbington, P., Blizard, R., Johnson, S., Nolan, F., Pilling, S., & King, M. (2006) · BMJ · doi:10.1136/bmj.38773.518322.7c · Cited by 273
Naturalistic evaluation of dialectical behavior therapy-oriented treatment for borderline personality disorder
Turner, R. M. (2000) · Cognitive and Behavioral Practice · doi:10.1016/s1077-7229(00)80052-8 · Cited by 268
Dialectical behaviour therapy skills training compared to standard group therapy in borderline personality disorder: a 3-month randomised controlled clinical trial
Soler, J., Pascual, J. C., Tiana, T., Cebrià, A., Barrachina, J., Campins, M. J., Gich, I., Alvarez, E., & Pérez, V. (2009) · Behaviour Research and Therapy · doi:10.1016/j.brat.2009.01.013 · Cited by 267
Cognitive behaviour therapy for schizophrenia
Jones, C., Cormac, I., Silveira da Mota Neto, J. I., & Campbell, C. (2004) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000524.pub2 · Cited by 269
Retracted
A comparison of the utility of dimensional and categorical representations of psychosis
VAN OS, J., GILVARRY, C., BALE, R., VAN HORN, E., TATTAN, T., WHITE, I., & MURRAY ON BEHALF OF THE UK700 GROUP, R. (1999) · Psychological Medicine · doi:10.1017/s0033291798008162 · Cited by 261
Effect of ω-3 Polyunsaturated Fatty Acids in Young People at Ultrahigh Risk for Psychotic Disorders: The NEURAPRO Randomized Clinical Trial
McGorry, P. D., Nelson, B., Markulev, C., Yuen, H. P., Schäfer, M. R., Mossaheb, N., Schlögelhofer, M., Smesny, S., Hickie, I. B., Berger, G. E., et al. (2017) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2016.2902 · Cited by 262
Ketamine has distinct electrophysiological and behavioral effects in depressed and healthy subjects
Nugent, A. C., Ballard, E. D., Gould, T. D., Park, L. T., Moaddel, R., Brutsche, N. E., & Zarate, C. A. (2019) · Molecular Psychiatry · doi:10.1038/s41380-018-0028-2 · Cited by 250
Delay discounting in schizophrenia
Heerey, E. A., Robinson, B. M., McMahon, R. P., & Gold, J. M. (2007) · Cognitive Neuropsychiatry · doi:10.1080/13546800601005900 · Cited by 248
Classical psychedelics for the treatment of depression and anxiety: A systematic review
Muttoni, S., Ardissino, M., & John, C. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2019.07.076 · Cited by 256
A multicenter, inpatient, phase 2, double-blind, placebo-controlled dose-ranging study of LY2140023 monohydrate in patients with DSM-IV schizophrenia
Kinon, B. J., Zhang, L., Millen, B. A., Osuntokun, O. O., Williams, J. E., Kollack-Walker, S., Jackson, K., Kryzhanovskaya, L., & Jarkova, N. (2011) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e318218dcd5 · Cited by 256
A randomized trial of a low-trapping nonselective N-methyl-D-aspartate channel blocker in major depression
Zarate, C. A., Mathews, D., Ibrahim, L., Chaves, J. F., Marquardt, C., Ukoh, I., Jolkovsky, L., Brutsche, N. E., Smith, M. A., & Luckenbaugh, D. A. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.10.019 · Cited by 255
Mechanisms of Dopaminergic and Serotonergic Neurotransmission in Tourette Syndrome: Clues from an In Vivo Neurochemistry Study with PET
Wong, D. F., Brašić, J. R., Singer, H. S., Schretlen, D. J., Kuwabara, H., Zhou, Y., Nandi, A., Maris, M. A., Alexander, M., Ye, W., et al. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301528 · Cited by 253
A Randomized Controlled Trial of Repeated Ketamine Administration for Chronic Posttraumatic Stress Disorder
Feder, A., Costi, S., Rutter, S. B., Collins, A. B., Govindarajulu, U., Jha, M. K., Horn, S. R., Kautz, M., Corniquel, M., Collins, K. A., et al. (2021) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2020.20050596 · Cited by 246
Substance use: a powerful predictor of relapse in schizophrenia
Swofford, C. D., Kasckow, J. W., Scheller-Gilkey, G., & Inderbitzin, L. B. (1996) · Schizophrenia Research · doi:10.1016/0920-9964(95)00068-2 · Cited by 247
Mood stabilisers plus risperidone or placebo in the treatment of acute mania: International, double-blind, randomised controlled trial
Yatham, L. N., Grossman, F., Augustyns, I., Vieta, E., & Ravindran, A. (2003) · British Journal of Psychiatry · doi:10.1192/bjp.182.2.141 · Cited by 248
Electroconvulsive Treatment Compared With Lithium in the Management of Manic States
Small, J. G. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800320037004 · Cited by 246
Applying clinical staging to young people who present for mental health care
Hickie, I. B., Scott, E. M., Hermens, D. F., Naismith, S. L., Guastella, A. J., Kaur, M., Sidis, A., Whitwell, B., Glozier, N., Davenport, T., et al. (2013) · Early Intervention in Psychiatry · doi:10.1111/j.1751-7893.2012.00366.x · Cited by 229
Effects of Low-Dose and Very Low-Dose Ketamine among Patients with Major Depression: a Systematic Review and Meta-Analysis
Xu, Y., Hackett, M., Carter, G., Loo, C., Gálvez, V., Glozier, N., Glue, P., Lapidus, K., McGirr, A., Somogyi, A. A., et al. (2016) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyv124 · Cited by 226
Evidence of basal pituitary–adrenal overactivity in first episode, drug naïve patients with schizophrenia
Ryan, M. C. M., Sharifi, N., Condren, R., & Thakore, J. H. (2004) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2003.08.011 · Cited by 225
Childhood-Onset Schizophrenia: A Double-Blind, Randomized Clozapine-Olanzapine Comparison
Shaw, P., Sporn, A., Gogtay, N., Overman, G. P., Greenstein, D., Gochman, P., Tossell, J. W., Lenane, M., & Rapoport, J. L. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.7.721 · Cited by 225
The plasma levels of interleukin-12 in schizophrenia, major depression, and bipolar mania: effects of psychotropic drugs.
Kim, Y.-K., Suh, I.-B., Kim, H., Han, C.-S., Lim, C.-S., Choi, S.-H., & Licinio, J. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001084 · Cited by 224
Sleep–wake cycles and cognitive functioning in schizophrenia
Bromundt, V., Köster, M., Georgiev-Kill, A., Opwis, K., Wirz-Justice, A., Stoppe, G., & Cajochen, C. (2011) · British Journal of Psychiatry · doi:10.1192/bjp.bp.110.078022 · Cited by 223
High-dose glycine added to olanzapine and risperidone for the treatment of schizophrenia
Heresco-Levy, U., Ermilov, M., Lichtenberg, P., Bar, G., & Javitt, D. C. (2004) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00707-8 · Cited by 222
Brain SPECT Imaging of Amphetamine-Induced Dopamine Release in Euthymic Bipolar Disorder Patients
Anand, A., Verhoeff, P., Seneca, N., Zoghbi, S. S., Seibyl, J. P., Charney, D. S., & Innis, R. B. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.7.1108 · Cited by 222
Cortisol Circadian Rhythm Alterations in Psychotic Major Depression
Keller, J., Flores, B., Gomez, R. G., Solvason, H. B., Kenna, H., Williams, G. H., & Schatzberg, A. F. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.10.014 · Cited by 217
Ethnicity, expressed emotion, attributions, and course of schizophrenia: family warmth matters
López, S. R., Nelson Hipke, K., Polo, A. J., Jenkins, J. H., Karno, M., Vaughn, C., & Snyder, K. S. (2004) · Journal of Abnormal Psychology · doi:10.1037/0021-843x.113.3.428 · Cited by 219
A Randomized, Placebo-Controlled, Crossover Pilot Trial of the Oral Selective NR2B Antagonist MK-0657 in Patients With Treatment-Resistant Major Depressive Disorder
Ibrahim, L., DiazGranados, N., Jolkovsky, L., Brutsche, N., Luckenbaugh, D. A., Herring, W. J., Potter, W. Z., & Zarate, C. A. (2012) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31825d70d6 · Cited by 220
Who Benefits From Supported Employment: A Meta-analytic Study
Campbell, K., Bond, G. R., & Drake, R. E. (2011) · Schizophrenia Bulletin · doi:10.1093/schbul/sbp066 · Cited by 219
Effects of long-term prolactin-raising antipsychotic medication on bone mineral density in patients with schizophrenia
Meaney, A. M., Smith, S., Howes, O. D., O'Brien, M., Murray, R. M., & O'Keane, V. (2004) · British Journal of Psychiatry · doi:10.1192/bjp.184.6.503 · Cited by 217
Minocycline as adjunctive therapy for patients with unipolar psychotic depression: An open-label study
Miyaoka, T., Wake, R., Furuya, M., Liaury, K., Ieda, M., Kawakami, K., Tsuchie, K., Taki, M., Ishihara, K., Araki, T., et al. (2012) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.02.002 · Cited by 212
The Motivation and Pleasure Scale–Self-Report (MAP-SR): Reliability and validity of a self-report measure of negative symptoms
Llerena, K., Park, S. G., McCarthy, J. M., Couture, S. M., Bennett, M. E., & Blanchard, J. J. (2013) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2012.12.001 · Cited by 217
Synch before you speak: Auditory hallucinations in schizophrenia
Ford, J. M., Roach, B. J., Faustman, W. O., & Mathalon, D. H. (2007) · American Journal of Psychiatry · doi:10.1176/ajp.2007.164.3.458 · Cited by 245
Effect of Long-Acting Injectable Antipsychotics vs Usual Care on Time to First Hospitalization in Early-Phase Schizophrenia: A Randomized Clinical Trial
Kane, J. M., Schooler, N. R., Marcy, P., Correll, C. U., Achtyes, E. D., Gibbons, R. D., & Robinson, D. G. (2020) · JAMA psychiatry · doi:10.1001/jamapsychiatry.2020.2076 · Cited by 208
Sensory Contributions to Impaired Prosodic Processing in Schizophrenia
Leitman, D. I., Foxe, J. J., Butler, P. D., Saperstein, A., Revheim, N., & Javitt, D. C. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.02.034 · Cited by 206
Maintenance Treatment With Varenicline for Smoking Cessation in Patients With Schizophrenia and Bipolar Disorder: A Randomized Clinical Trial
Evins, A. E., Cather, C., Pratt, S. A., Pachas, G. N., Hoeppner, S. S., Goff, D. C., Achtyes, E. D., Ayer, D., & Schoenfeld, D. A. (2014) · JAMA · doi:10.1001/jama.2013.285113 · Cited by 207
Atypical Antipsychotics Part I: Pharmacology, Pharmacokinetics, and Efficacy
Markowitz, J. S., Brown, C. S., & Moore, T. R. (1999) · Annals of Pharmacotherapy · doi:10.1345/aph.17215 · Cited by 208
Regional homogeneity in depression and its relationship with separate depressive symptom clusters: a resting-state fMRI study
Yao, Z., Wang, L., Lu, Q., Liu, H., & Teng, G. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2008.10.013 · Cited by 205
Event-Related fMRI of Frontotemporal Activity During Word Encoding and Recognition in Schizophrenia
Ragland, J. D., Gur, R. C., Valdez, J., Turetsky, B. I., Elliott, M., Kohler, C., Siegel, S., Kanes, S., & Gur, R. E. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.6.1004 · Cited by 206
The latent structure of negative symptoms in schizophrenia
Strauss, G. P., Nuñez, A., Ahmed, A. O., Barchard, K. A., Granholm, E., Kirkpatrick, B., Gold, J. M., & Allen, D. N. (2018) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2018.2475 · Cited by 204
Development and psychometric evaluation of the Discrimination and Stigma Scale (DISC)
Brohan, E., Clement, S., Rose, D., Sartorius, N., Slade, M., & Thornicroft, G. (2013) · Psychiatry Research · doi:10.1016/j.psychres.2013.03.007 · Cited by 196
Clinical and Biological Effects of Mifepristone Treatment for Psychotic Depression
Flores, B. H., Kenna, H., Keller, J., Solvason, H. B., & Schatzberg, A. F. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300884 · Cited by 203
Does relapse contribute to treatment resistance? antipsychotic response in first- vs. second-episode schizophrenia.
Takeuchi, H., Siu, C., Remington, G., Fervaha, G., Zipursky, R. B., Foussias, G., & Agid, O. (2019) · Neuropsychopharmacology · doi:10.1038/s41386-018-0278-3 · Cited by 200
Psychological interventions to reduce positive symptoms in schizophrenia: systematic review and network meta‐analysis
Bighelli, I., Salanti, G., Huhn, M., Schneider‐Thoma, J., Krause, M., Reitmeir, C., Wallis, S., Schwermann, F., Pitschel‐Walz, G., Barbui, C., et al. (2018) · World Psychiatry · doi:10.1002/wps.20577 · Cited by 199
Quantitative and Qualitative Aspects of the Social Network in Schizophrenic Patients Living in the Community. Relationship To Sociodemographic Characteristics and Clinical Factors and Subjective Quality of Life
Bengtsson-Tops, A., & Hansson, L. (2001) · International Journal of Social Psychiatry · doi:10.1177/002076400104700307 · Cited by 196
N-Methyl-D-Aspartate Receptor Antagonist Effects on Prefrontal Cortical Connectivity Better Model Early Than Chronic Schizophrenia
Anticevic, A., Corlett, P. R., Cole, M. W., Savic, A., Gancsos, M., Tang, Y., Repovs, G., Murray, J. D., Driesen, N. R., Morgan, P. T., et al. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.07.022 · Cited by 181
Negative symptoms of schizophrenia: a problem that will not go away
Stahl, S. M., & Buckley, P. F. (2007) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2006.00947.x · Cited by 195
Sub-chronic impact of cannabinoids in street cannabis on cognition, psychotic-like symptoms and psychological well-being
Morgan, C. J. A., Gardener, C., Schafer, G., Swan, S., Demarchi, C., Freeman, T. P., Warrington, P., Rupasinghe, I., Ramoutar, A., Tan, N., et al. (2012) · Psychological Medicine · doi:10.1017/s0033291711001322 · Cited by 195
Dissecting corollary discharge dysfunction in schizophrenia
Ford, J. M., Gray, M., Faustman, W. O., Roach, B. J., & Mathalon, D. H. (2007) · Psychophysiology · doi:10.1111/j.1469-8986.2007.00533.x · Cited by 192
Is the superior efficacy of new generation antipsychotics an artifact of LOCF?
Leucht, S., Engel, R. R., Bauml, J., & Davis, J. M. (2006) · Schizophrenia Bulletin · doi:10.1093/schbul/sbl025 · Cited by 193
Acute and continuation risperidone monotherapy in bipolar mania: a 3-week placebo-controlled trial followed by a 9-week double-blind trial of risperidone and haloperidol
Smulevich, A. B., Khanna, S., Eerdekens, M., Karcher, K., Kramer, M., & Grossman, F. (2005) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2004.06.003 · Cited by 192
Cannabidiol monotherapy for treatment-resistant schizophrenia
Zuardi, A. W., Hallak, J. E. C., Dursun, S. M., Morais, S. L., Sanches, R. F., Musty, R. E., & Crippa, J. A. S. (2006) · Journal of Psychopharmacology · doi:10.1177/0269881106060967 · Cited by 192
Recovery and serious mental illness: a review of current clinical and research paradigms and future directions.
Leonhardt, B. L., Huling, K., Hamm, J. A., Roe, D., Hasson-Ohayon, I., McLeod, H. J., & Lysaker, P. H. (2017) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2017.1378099 · Cited by 195
A randomized controlled trial of the effects of brief mindfulness meditation on anxiety symptoms and systolic blood pressure in Chinese nursing students.
Chen, Y., Yang, X., Wang, L., & Zhang, X. (2013) · Nurse Education Today · doi:10.1016/j.nedt.2012.11.014 · Cited by 189
Patients with Schizophrenia have a Reduced Neural Response to Both Unpredictable and Predictable Primary Reinforcers
Waltz, J. A., Schweitzer, J. B., Gold, J. M., Kurup, P. K., Ross, T. J., Jo Salmeron, B., Rose, E. J., McClure, S. M., & Stein, E. A. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2008.214 · Cited by 186
Impairment across executive functions in recurrent major depression
Stordal, K. I., Lundervold, A. J., Egeland, J., Mykletun, A., Asbjørnsen, A., Landrø, N. I., Roness, A., Rund, B. R., Sundet, K., Oedegaard, K. J., et al. (2004) · Nordic Journal of Psychiatry · doi:10.1080/08039480310000789 · Cited by 180
Supported employment for adults with severe mental illness
Kinoshita, Y., Furukawa, T. A., Kinoshita, K., Honyashiki, M., Omori, I. M., Marshall, M., Bond, G. R., Huxley, P., Amano, N., & Kingdon, D. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008297.pub2 · Cited by 182
Processing of global, but not local, motion direction is deficient in schizophrenia
Chen, Y. (2003) · Schizophrenia Research · doi:10.1016/s0920-9964(02)00222-0 · Cited by 183
Combined dexamethasone/corticotropin-releasing hormone test in acute and remitted manic patients, in acute depression, and in normal controls: I
Schmider, J., Lammers, C.-H., Gotthardt, U., Dettling, M., Holsboer, F., & Heuser, I. J. E. (1995) · Biological Psychiatry · doi:10.1016/0006-3223(95)00064-x · Cited by 179
Weakened center-surround interactions in visual motion processing in schizophrenia
Tadin, D., Kim, J., Doop, M. L., Gibson, C., Lappin, J. S., Blake, R., & Park, S. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.2592-06.2006 · Cited by 182
Low-frequency BOLD fluctuations demonstrate altered thalamocortical connectivity in schizophrenia
Welsh, R. C., Chen, A. C., & Taylor, S. F. (2010) · Schizophrenia Bulletin · doi:10.1093/schbul/sbn145 · Cited by 181
Disruption of anterior insula modulation of large-scale brain networks in schizophrenia
Moran, L. V., Tagamets, M. A., Sampath, H., O’Donnell, A., Stein, E. A., Kochunov, P., & Hong, L. E. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.02.029 · Cited by 181
Ketamine for the acute treatment of severe suicidal ideation: double blind, randomised placebo controlled trial
Abbar, M., Demattei, C., El-Hage, W., Llorca, P.-M., Samalin, L., Demaricourt, P., Gaillard, R., Courtet, P., Vaiva, G., Gorwood, P., et al. (2022) · BMJ · doi:10.1136/bmj-2021-067194 · Cited by 181
Gender differences in the clinical expression of schizophrenia
Shtasel, D. L., Gur, R. E., Gallacher, F., Heimberg, C., & Gur, R. C. (1992) · Schizophrenia Research · doi:10.1016/0920-9964(92)90016-x · Cited by 176
Ketamine versus midazolam in bipolar depression with suicidal thoughts: A pilot midazolam‐controlled randomized clinical trial
Grunebaum, M. F., Ellis, S. P., Keilp, J. G., Moitra, V. K., Cooper, T. B., Marver, J. E., Burke, A. K., Milak, M. S., Sublette, M. E., Oquendo, M. A., et al. (2017) · Bipolar Disorders · doi:10.1111/bdi.12487 · Cited by 174
A randomized clinical trial of MK-0777 for the treatment of cognitive impairments in people with schizophrenia
Buchanan, R. W., Keefe, R. S. E., Lieberman, J. A., Barch, D. M., Csernansky, J. G., Goff, D. C., Gold, J. M., Green, M. F., Jarskog, L. F., Javitt, D. C., et al. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.09.052 · Cited by 172
A randomized, double-blind comparison of olanzapine/fluoxetine combination, olanzapine, fluoxetine, and venlafaxine in treatment-resistant depression
Corya, S. A., Williamson, D., Sanger, T. M., Briggs, S. D., Case, M., & Tollefson, G. (2006) · Depression and Anxiety · doi:10.1002/da.20130 · Cited by 170
Impaired MMN/P3a complex in first-episode psychosis: cognitive and psychosocial associations
Hermens, D. F., Ward, P. B., Hodge, M. A. R., Kaur, M., Naismith, S. L., & Hickie, I. B. (2010) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.03.019 · Cited by 170
Disability and schizophrenia: a systematic review of experienced psychosocial difficulties
Świtaj, P., Anczewska, M., Chrostek, A., Sabariego, C., Cieza, A., Bickenbach, J., & Chatterji, S. (2012) · BMC Psychiatry · doi:10.1186/1471-244x-12-193 · Cited by 170
Galantamine for the treatment of cognitive impairments in people with schizophrenia
Buchanan, R. W., Conley, R. R., Dickinson, D., Ball, M. P., Feldman, S., Gold, J. M., & McMahon, R. P. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.07050724 · Cited by 170
Affective dysregulation and reality distortion: a 10-year prospective study of their association and clinical relevance
van Rossum, I., Dominguez, M.-D.-G., Lieb, R., Wittchen, H.-U., & van Os, J. (2011) · Schizophrenia Bulletin · doi:10.1093/schbul/sbp101 · Cited by 170
Dexamethasone suppression test in schizophrenia: relationship to symptomatology, ventricular enlargement, and outcome
Tandon, R., Mazzara, C., DeQuardo, J., Craig, K. A., Meador-Woodruff, J. H., Goldman, R., & Greden, J. F. (1991) · Biological Psychiatry · doi:10.1016/0006-3223(91)90353-n · Cited by 168
Effects of a Dopamine Agonist Piribedil in Depressed Patients: Relationship of Pretreatment Homovanillic Acid to Antidepressant Response
Post, R. M. (1978) · Archives of General Psychiatry · doi:10.1001/archpsyc.1978.01770290091008 · Cited by 168
The Role of Electroconvulsive Therapy (ECT) in Bipolar Disorder: Effectiveness in 522 Patients with Bipolar Depression, Mixed-state, Mania and Catatonic Features
Perugi, G., Medda, P., Toni, C., Mariani, M., Socci, C., & Mauri, M. (2017) · Current Neuropharmacology · doi:10.2174/1570159x14666161017233642 · Cited by 167
Best practices for remote psychological assessment via telehealth technologies.
Luxton, D. D., Pruitt, L. D., & Osenbach, J. E. (2014) · Professional Psychology: Research and Practice · doi:10.1037/a0034547 · Cited by 162
The expression and experience of emotion in schizophrenia: a study of social interactions
Aghevli, M. A., Blanchard, J. J., & Horan, W. P. (2003) · Psychiatry Research · doi:10.1016/s0165-1781(03)00133-1 · Cited by 165
Psychotic symptom and cannabis relapse in recent-onset psychosis: Prospective study
Hides, L., Dawe, S., Kavanagh, D. J., & Young, R. M. (2006) · British Journal of Psychiatry · doi:10.1192/bjp.bp.105.014308 · Cited by 166
Acute effects of the selective cholinergic channel activator (nicotinic agonist) ABT-418 in Alzheimer's disease
Potter, A., Corwin, J., Lang, J., Piasecki, M., Lenox, R., & Newhouse, P. A. (1999) · Psychopharmacology · doi:10.1007/s002130050897 · Cited by 163
Mindfulness- and acceptance-based interventions for psychosis: Our current understanding and a meta-analysis
Louise, S., Fitzpatrick, M., Strauss, C., Rossell, S. L., & Thomas, N. (2018) · Schizophrenia Research · doi:10.1016/j.schres.2017.05.023 · Cited by 160
Occupational Engagement in Persons With Schizophrenia: Relationships to Self-Related Variables, Psychopathology, and Quality of Life
Bejerholm, U., & Eklund, M. (2007) · American Journal of Occupational Therapy · doi:10.5014/ajot.61.1.21 · Cited by 163
Systematic reviews of the effectiveness of day care for people with severe mental disorders: (1) Acute day hospital versus admission; (2) Vocational rehabilitation; (3) Day hospital versus outpatient care
Marshall, M., Sledge, W., Wiersma, D., Crowther, R., Kluiter, H., Bond, G. R., Almaraz-Serrano, A., Roberts, C., Huxley, P., Creed, F., et al. (2001) · Health Technology Assessment · doi:10.3310/hta5210 · Cited by 158
Sleep architecture and its clinical correlates in first episode and neuroleptic-naive patients with schizophrenia
Poulin, J., Daoust, A.-M., Forest, G., Stip, E., & Godbout, R. (2003) · Schizophrenia Research · doi:10.1016/s0920-9964(02)00346-8 · Cited by 160
Brain-Derived Neurotrophic Factor and Initial Antidepressant Response to an N-Methyl-D-Aspartate Antagonist
Machado-Vieira, R., Yuan, P., Brutsche, N., DiazGranados, N., Luckenbaugh, D., Manji, H. K., & Zarate, C. A. (2009) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.08m04659 · Cited by 155
Adjunctive lithium treatment in the prevention of suicidal behaviour in depressive disorders: a randomised, placebo‐controlled, 1‐year trial
Lauterbach, E., Felber, W., Müller‐Oerlinghausen, B., Ahrens, B., Bronisch, T., Meyer, T., Kilb, B., Lewitzka, U., Hawellek, B., Quante, A., et al. (2008) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2008.01266.x · Cited by 154
The Relative Sensitivity of the Clinical Global Impressions Scale and the Brief Psychiatric Rating Scale in Antipsychotic Drug Trials
Leucht, S., & Engel, R. R. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300873 · Cited by 154
Abnormal Responses to Monetary Outcomes in Cortex, but not in the Basal Ganglia, in Schizophrenia
Waltz, J. A., Schweitzer, J. B., Ross, T. J., Kurup, P. K., Salmeron, B. J., Rose, E. J., Gold, J. M., & Stein, E. A. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.126 · Cited by 151
The effects of low‐dose ketamine on the prefrontal cortex and amygdala in treatment‐resistant depression: A randomized controlled study
Li, C., Chen, M., Lin, W., Hong, C., Yang, B., Liu, R., Tu, P., & Su, T. (2016) · Human Brain Mapping · doi:10.1002/hbm.23085 · Cited by 152
Impairments in generation of early-stage transient visual evoked potentials to magno- and parvocellular-selective stimuli in schizophrenia
Schechter, I., Butler, P. D., Zemon, V. M., Revheim, N., Saperstein, A. M., Jalbrzikowski, M., Pasternak, R., Silipo, G., & Javitt, D. C. (2005) · Clinical Neurophysiology · doi:10.1016/j.clinph.2005.06.013 · Cited by 151
Aripiprazole versus other atypical antipsychotics for schizophrenia
Khanna, P., Suo, T., Komossa, K., Ma, H., Rummel-Kluge, C., El-Sayeh, H. G., Leucht, S., & Xia, J. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006569.pub5 · Cited by 151
The role of IL-12 and TGF-β1 in the pathophysiology of major depressive disorder
Lee, K.-M., & Kim, Y.-K. (2006) · International Immunopharmacology · doi:10.1016/j.intimp.2006.03.015 · Cited by 150
Oxytocin-Augmented Social Cognitive Skills Training in Schizophrenia
Davis, M. C., Green, M. F., Lee, J., Horan, W. P., Senturk, D., Clarke, A. D., & Marder, S. R. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.68 · Cited by 149

Authors: Overall, J. E., & Gorham, D. R.
Affiliations: Kansas State University (US)
V. A. Central N.P. Research Lab.
Venue: Psychological Reports
Publisher: SAGE Publications
Published: 1962-06
Volume: 10
Issue: 3
Pages: 799-812
ISSN: 0033-2941 (ISSN-L)
1558-691X
DOI: 10.2466/pr0.1962.10.3.799
OpenAlex: W2020844317
Semantic Scholar: 9818624e99c64afc33c5c6b09bd7e4bede62fd09
Cited by: 11,090
References: 4
Citations by year: 2026: 164 · 2025: 184 · 2024: 222 · 2023: 165 · 2022: 221 · 2021: 258 · 2020: 241 · 2019: 318 · 2018: 319 · 2017: 286 · 2016: 290 · 2015: 297 · 2014: 330 · 2013: 328 · 2012: 323
FWCI: 20.83
Type: journal article
Language: en
Open access: closed
Licence: journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
Locations: Psychological Reports (publishedVersion)
Open Scholarship Institutional Repository (Washington University in St. Louis) (submittedVersion)
Topics: Social Sciences › Psychology › Applied Psychology › Psychological Testing and Assessment
Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
Social Sciences › Decision Sciences › Management Science and Operations Research › Psychometric Methodologies and Testing
Keywords: Brief Psychiatric Rating Scale, psychiatric rating scales, psychopathology assessment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The Brief Psychiatric Rating Scale.

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks